Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Trigilio currently holds 26,000 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Trigilio has been a net seller of CGEM stock. They have purchased $47.3K and sold $689.7K worth of shares.
Jeffrey Trigilio's most recent insider trade was on Apr 13, 2026, when they sold 4,000 shares at $0.00 per share.
Jeffrey Trigilio serves as Executive at Cullinan Oncology, Inc. (CGEM). They have executed 29 insider transactions totaling $737.0K over their tenure at the company.
Jeffrey Trigilio holds the position of Executive at Cullinan Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Jeffrey Trigilio has shown a selling trading pattern, with $47.3K in total purchases and $689.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey Trigilio was on Sep 8, 2021, when they sold $274.5K worth of CGEM shares. This transaction involved 9,513 shares at $28.85 per share.
Jeffrey Trigilio currently owns 26,000 shares of Cullinan Oncology, Inc. (CGEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Trigilio's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Trigilio has 29 Form 4 filings on record as an insider at Cullinan Oncology, Inc..
Set alerts for Jeffrey Trigilio and 40,000+ other insiders.